Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Diva Laboratories, Ltd. (4153:TWSE), powered by AI.
Diva Laboratories, Ltd. is currently trading at $30.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Diva Laboratories, Ltd. on Alpha Lenz.
View Diva Laboratories, Ltd.'s valuation metrics on Alpha Lenz.
“Diva Laboratories, Ltd.'s ROE is 8.7%. Explore profitability and growth together.”
Ask for details →Diva Laboratories, Ltd. specializes in the development, manufacture, and sale of advanced medical and industrial display solutions. Established in 1995 and headquartered in New Taipei City, Diva serves global clients with a portfolio that includes surgical and radiology displays, touch-based human-machine interface products, and precision video solutions for both healthcare and professional environments. The company is notably a key supplier of ICU vital sign monitors to GE Healthcare and one of only two providers of MRI in-room monitors worldwide, highlighting its impact on critical medical infrastructure. Diva also extends its technology into industrial sectors such as railway and maritime navigation, supporting leading OEM and ODM customers. With medical applications comprising the majority of its sales, Diva Laboratories plays a pivotal role enabling accurate visualization and system integration for healthcare and industrial professionals across major international markets.
“Diva Laboratories, Ltd.'s ROE is 8.7%. Explore profitability and growth together.”
Ask for details →Diva Laboratories, Ltd. (ticker: 4153) is a company listed on TWSE in the Healthcare sector (Diagnostics & Research).
The current price is 30 with a P/E ratio of -x and P/B of -x.
ROE is 8.69% and operating margin is 12.59%. Annual revenue is $869M.